Skip to content
value.today

METabolic Solutions Development Co.

🇺🇸 Kalamazoo, Michigan, USAPharmaceuticalsFounded 2006
Total raised
$38 M
3 rounds on record
Latest round
$16 M
Aug 2012
First round on record
Sep 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of METabolic Solutions Development Co.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2012$16 MNo. 3$10 to $50 million

METabolic Solutions Development Co.: Raise no. 3, Aug 2012

Investors in this round

30 investors had bought by the notice of Sep 24, 2015: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $18 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Angeline Shashlo · Executive Officer
  • Gerald Callahan · Executive Officer, Director
  • Gerard Colca · Executive Officer, Director
  • James Vanderlugt · Executive Officer
  • Mark Olesnavage · Executive Officer, Director
  • Rolf Kletzien · Executive Officer, Director
  • Stephen Benoit · Executive Officer, Director
  • Jim Schultz · Director
  • Michael Jandernoa · Director
  • Robert Zerbe · Director
  • William Parfet · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Benoit, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Sep 24, 2015. Read the notice at the SEC.

debt, optionsSEC
Jul 2011$7 MNo. 2$2 to $10 million

METabolic Solutions Development Co.: Raise no. 2, Jul 2011

Investors in this round

23 investors had bought by the notice of Aug 11, 2011: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$600,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Angeline Shashlo · Executive Officer
  • Gerald Callahan · Executive Officer, Director
  • Gerard Colca · Executive Officer, Director
  • James VanderLugt · Executive Officer
  • Mark Olesnavage · Executive Officer, Director
  • Rolf Kletzien · Executive Officer, Director
  • Stephen Benoit · Executive Officer
  • Michael Jandernoa · Director
  • William Parfet · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Benoit, Cheif Executive Officer. Source: SEC Form D, newest notice filed Aug 11, 2011. Read the notice at the SEC.

equitySEC
Sep 2010$15 MNo. 1$10 to $50 million

METabolic Solutions Development Co.: Raise no. 1, Sep 2010

Investors in this round

24 investors had bought by the notice of Oct 7, 2010: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $24 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Michigan

People named in the notice

  • Angeline Shashlo · Executive Officer
  • Gerald Callahan · Executive Officer, Director
  • Gerard Colca · Executive Officer, Director
  • James VanderLugt · Executive Officer
  • Rolf Kletzien · Executive Officer, Director
  • John Landis · Director
  • Mark Olesnavage · Director
  • Michael Jandernoa · Director
  • William Parfet · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds of the offering will be used, among other things, for general corporate purposes, including payment of salary to the Company's executive officers.”

Signed by Gerard Colca, President. Source: SEC Form D, newest notice filed Oct 7, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • METabolic Solutions Development Co. chose not to state its revenue in its newest notice of a funding round (Sep 2015).

    SEC Form D · Sep 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2015

That is all the official record says: METabolic Solutions Development Co. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of METabolic Solutions Development Co. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 30 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by METabolic Solutions Development Co.
NameRoleNamed in
Angeline ShashloExecutive officerSep 2015
Gerald CallahanExecutive officerSep 2015
Gerard ColcaExecutive officerSep 2015
James VanderlugtExecutive officerSep 2015
Mark OlesnavageExecutive officerSep 2015
Rolf KletzienExecutive officerSep 2015
Stephen BenoitExecutive officerSep 2015
James VanderLugtExecutive officerAug 2011
Gerald CallahanDirectorSep 2015
Gerard ColcaDirectorSep 2015
Jim SchultzDirectorSep 2015
Mark OlesnavageDirectorSep 2015
Michael JandernoaDirectorSep 2015
Robert ZerbeDirectorSep 2015
Rolf KletzienDirectorSep 2015
Stephen BenoitDirectorSep 2015
William ParfetDirectorSep 2015
John LandisDirectorAug 2012